Begin main content

Search

We found 67 result(s)

New at CADTH - November 2018

Published on: November 12, 2018
Result type: Reports
Product Line: New at CADTH

NEWS AND EVENTS The CADTH Drug Portfolio and Medical Devices Portfolio Information Sessions were held on November 1. The presentations for both sessions are now available online here and here respectively. Save the date. The 2019 CADTH Symposium is being held in Edmonton, Alberta, from April 14 to 16, 2019. Applications are also now open for tra...

New at CADTH - October 2018

Published on: October 10, 2018
Result type: Reports
Product Line: New at CADTH

NEWS AND EVENTS CADTH is hosting two Medical Devices and Drug Portfolio Information Sessions on Thursday, November 1, 2018, from 9:30 a.m. to 12:00 p.m. and from 1:30 p.m. to 4:00 p.m. EDT, respectively. Interested participants can attend in person, at 150 King Street West, Toronto, or via webinar. This annual event is an opportunity for all int...

New at CADTH - September 2018

Published on: September 17, 2018
Result type: Reports
Product Line: New at CADTH

NEWS & EVENTS CADTH was pleased to have announced the appointment of Mr. David Agnew, President of Seneca College, to Chair of the CADTH Board of Directors. Health Canada, CADTH, and INESSS are hosting a webinar September 26, 2018, from 10:00 AM to 12:00 PM EDT to provide details on the aligned review process that was announced in June 2018....

New at CADTH — July and August 2018

Published on: July 6, 2018
Result type: Reports
Product Line: New at CADTH

NEWS CDR Update 137 / pCODR Update 67: Highlights the new aligned drug reviews from Health Canada, CADTH (through our Common Drug Review and pan-Canadian Oncology Drug Review programs),  and the Institut national d’excellence en santé et en services sociaux (INESSS), which will help reduce the time between market authorization and drug reimburse...

New at CADTH — June 2018

Published on: June 12, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review CDR Update — Issue 136: Highlights in this issue include details about the updated CADTH Canadian Drug Expert Committee meeting schedule, an updated Advance Notification Form, an update on drug plan participation in pre-submission meetings, and details about pending changes to the Key M...

New at CADTH — May 2018

Published on: May 14, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Ocrelizumab (Ocrevus): Primary progressive multiple sclerosis Nitisinone (MDK-Nitisinone): Hereditary tyrosinemia type I Latanoprost (Monoprost): Glaucoma and ocular hypertension CADTH pan-Canadian Oncology Drug Review (pCODR) Alectinib (Alecensaro): Locally advanced or metastatic non‒s...

New at CADTH — April 2018

Published on: April 23, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review (CDR) Tocilizumab (Actemra): Giant cell arteritis (GCA) Tenofovir alafenamide (Vemlidy): Hepatitis B, chronic CDR Update 135: Application Fees for CADTH Pharmaceutical Reviews — Adjustment CADTH pan-Canadian Oncology Drug Review (pCODR) Pembrolizumab (Keytruda): Metastatic Urothelial Ca...

New at CADTH — March 2018

Published on: March 16, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Nitisinone (Orfadin): Hereditary tyrosinemia type 1 Guselkumab (Tremfya): Psoriasis, moderate-to-severe plaque Infliximab (Renflexis): rheumatoid arthritis, ankylosing spondylitis, adult Crohn’s disease, pediatric Crohn’s disease, fistulising Crohn’s disease, adult ulcerative colitis, p...

New at CADTH — February 2018

Published on: February 16, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Migalastat (Galafold): Fabry Disease Cysteamine bitartrate (Procysbi): Nephropathic cystinosis Glecaprevir pibrentasvir (Maviret): Chronic Hepatitis C Apomorphine hydrochloride (Movapo): Parkinson's disease Sofosbuvir velpatasvir voxilaprevir (Vosevi): Chronic Hepatitis C CADTH pan-Cana...

New at CADTH — January 2018

Published on: January 11, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Read the following CDR Update to find out what’s happening in CDR: Issue 132 — Update on Revised Process for Biosimilars, and Clarification Regarding Eligibility Assessments for Resubmissions. Nusinersen (Spinraza): Spinal Muscular Atrophy CADTH pan-Canadian Oncology Drug Review (pCODR)...